David E. Lenz

Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning

Yuejin Huang, Yue Huang, Hernán Baldassarre et al. · Proceedings of the National Academy of Sciences · 2007 · 216 citations · Full text

Veterinary Medicine, Biotechnology, Toxicology +13

Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates.

Clarence A. Broomfield, Donald M. Maxwell, Richard P. Solana et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 187 citations

Medicine, Pharmacology, Toxicology +10

The effects of blood flow and detoxification on in vivo cholinesterase inhibition by soman in rats

Donald M. Maxwell, David E. Lenz, William A. Groff et al. · Toxicology and Applied Pharmacology · 1987 · 119 citations

Medicine, Neuroscience, Pharmacology +12

Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys

David E. Lenz, Donald M. Maxwell, Irwin Koplovitz et al. · Chemico-Biological Interactions · 2005 · 118 citations

Pharmacy, Pharmacology, Toxicology +7

(07) In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia™) as a potential nerve agent bioscavenger

Douglas M. Cerasoli, E Griffiths, Bhupendra P. Doctor et al. · Chemico-Biological Interactions · 2005 · 84 citations

Life Sciences, Neuroscience, Pharmacology +9